WIN-17317-3

N/A

Report date: 2025/02/05 15:16:54
NME

Base Information

Drug NameWIN-17317-3
Drug Alias NameWIN-17317-3WIN 17317-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type II alpha subunit blockers
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Innsbruck
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Innsbruck
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A